Editorial: A Step Back to Leap Forward—Strategic Nucleos(t)ide Analogue Discontinuation Towards HBV Functional Cure
Alimentary Pharmacology & Therapeutics · 2026-01 · 63 (2) · 303-305
DOI: 10.1111/apt.70352 ↗Kurz gefasst
Editorial in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 02.09.2025. Verfasst von Xuwen Xu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- State Key Laboratory of Organ Failure Research, Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Guangdong Provincial…
Zitieren
APA
Xu, X., Lu, A., & Cai, S. (2026). Editorial: A Step Back to Leap Forward—Strategic Nucleos(t)ide Analogue Discontinuation Towards HBV Functional Cure. Alimentary Pharmacology & Therapeutics, 63(2), 303-305. https://doi.org/10.1111/apt.70352
Vancouver
Xu X, Lu A, Cai S. Editorial: A Step Back to Leap Forward—Strategic Nucleos(t)ide Analogue Discontinuation Towards HBV Functional Cure. Alimentary Pharmacology & Therapeutics. 2026;63(2):303-305. doi:10.1111/apt.70352
BibTeX
@article{Xu2026,
author = {Xu, Xuwen and Lu, Aili and Cai, Shaohang},
title = {Editorial: A Step Back to Leap Forward—Strategic Nucleos(t)ide Analogue Discontinuation Towards HBV Functional Cure},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {63},
number = {2},
pages = {303--305},
doi = {10.1111/apt.70352}
}
EUVIMED